يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Svetlana Kopishinskaya"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    دورية أكاديمية

    المساهمون: профессор А.В.Густов

    المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 7, No 3 (2015); 75-79 ; Неврология, нейропсихиатрия, психосоматика; Vol 7, No 3 (2015); 75-79 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2015-3

    وصف الملف: application/pdf

    العلاقة: https://nnp.ima-press.net/nnp/article/view/535/508Test; Иллариошкин СН, Руденская ГЕ, Иванова-Смоленская ИА и др. Наследственные атаксии и параплегии. Москва: МЕДпресинформ; 2006. 416 с. [Illarioshkin SN, Rudenskaya GE, Ivanova-Smolenskaya IA, et al. Nasledstvennye ataksii i paraplegii [Hereditary ataxia and paraplegia]. Moscow: MEDpress-inform; 2006. 416 p.]; Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012 Nov 14;18(42):6036-59. doi:10.3748/wjg.v18.i42.6036.; Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012 Feb 7;10:13. doi:10.1186/1741-7015-10-13.; Hadjivassiliou M, MКki M, Sanders DS, Williamson CA. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology. 2006 Feb 14;66(3):373-7.; Mittelbronn M, Schittenhelm J, Bakos G, et al. CD8(+)/perforin/granzyme B(+) effector cells infiltrating cerebellum and inferior olives in gluten ataxia. Neuropathology. 2010 Feb 1;30(1):92-6. doi:10.1111/j.1440-1789.2009.01042.x. Epub 2009 Jul 19.; Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998 Nov 14;352(9140):1582-5.; Hadjivassiliou M, Sanders DS, Woodroofe N, et al. Gluten ataxia. Cerebellum. 2008;7(3):494-8. doi:10.1007/s12311-008-0052-x.; Fung VS, Duggins A, Morris JG, Lorentz IT. Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia. Mov Disord. 2000 Jul;15(4):732-4.; Tijssen MA, Thom M, Ellison DW, et al. Cortical myoclonus and cerebellar pathology. Neurology. 2000 Mar 28;54(6):1350-6.; Habek M, Hojsak I, Barun B, Brinar VV. Downbeat nystagmus, ataxia and spastic tetraparesis due to coeliac disease. Neurol Sci. 2011 Oct;32(5):911-4. doi:10.1007/s10072- 011-0506-7. Epub 2011 Mar 10.; Hadjivassiliou M, Aeschlimann P, Strigun A, et al. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008 Sep;64(3):332-43. doi:10.1002/ana.21450.; Hadjivassiliou M, Boscolo S, Davies-Jones GA, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology. 2002 Apr 23;58(8):1221-6.; Hadjivassiliou M, Wallis LI, Hoggard N, et al. MR spectroscopy and atrophy in Gluten, Friedreich's and SCA6 ataxias. Acta Neurol Scand. 2012 Aug;126(2):138-43. doi:10.1111/j.1600-0404.2011.01620.x. Epub 2011 Nov 10.; Currie S, Hadjivassiliou M, Clark MJ, et al. Should we be 'nervous' about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurological opinion. J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1216-21. doi:10.1136/jnnp-2012-303281. Epub 2012 Aug 20.; Mulder CJ, van Wanrooij RL, Bakker SF, et al. Gluten-free diet in gluten-related disorders. Dig Dis. 2013;31(1):57-62. doi:10.1159/000347180. Epub 2013 Jun 17.; Kaukinen K, Lindfors K, MКki M. Advances in the treatment of coeliac disease: an immunopathogenic perspective. Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):36-44. doi:10.1038/nrgastro.2013.141. Epub 2013 Aug 6.; Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med. 2011 Jun;269(6):604-13. doi:10.1111/j.1365-2796.2011.02376.x.; Szmulewicz DJ, McLean CA, Rodriguez ML, et al. Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS. Neurology. 2014 Apr 22;82(16): 1410-5. doi:10.1212/WNL.0000000000000352. Epub 2014 Mar 28.; Lines MA, Jobling R, Brady L, et al. Peroxisomal D-bifunctional protein deficiency: three adults diagnosed by whole-exome sequencing. Neurology. 2014 Mar 18;82(11):963-8. doi:10.1212/WNL.0000000000000219. Epub 2014 Feb 19.; Shimazaki H, Honda J, Naoi T, et al. Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation. J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1024-8. doi:10.1136/jnnp-2013-306981. Epub 2014 Feb 12.; El Euch-Fayache G, Bouhlal Y, Amouri R, et al. Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency. Brain. 2014 Feb;137(Pt 2):402-10. doi:10.1093/brain/awt339. Epub 2013 Dec 25.; Deik A, Saunders-Pullman R. Atypical presentation of late-onset Tay-Sachs disease. Muscle Nerve. 2014 May;49(5):768-71. doi:10.1002/mus.24146. Epub 2014 Feb 24.; Mead S, Gandhi S, Beck J, et al. A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med. 2013 Nov 14;369(20):1904-14. doi:10.1056/NEJMoa1214747.; Koike H, Sobue G. Sjogren's syndromeassociated neuropathy. Brain Nerve. 2013 Nov;65(11):1333-42.; Matsufuji M, Osaka H, Gotoh L, et al. Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2. Pediatr Neurol. 2013 Dec;49(6):477-81. doi:10.1016/j.pediatrneurol.2013.07.012. Epub 2013 Oct 1.; Lovan A, Ihtsham ul Haq, Balakrishnan N. Diagnostic challenges in movement disorders: Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia (SANDO) syndrome. BMJ Case Rep. 2013 Aug 30;2013. pii: bcr2013010343. doi:10.1136/bcr-2013-010343.; Swarup V, Srivastava AK, Padma MV, Rajeswari MR. Quantitative profiling and identification of differentially expressed plasma proteins in Friedreich's ataxia. J Neurosci Res. 2013 Nov;91(11):1483-91. doi:10.1002/jnr.23262. Epub 2013 Aug 30.; Duquette A, Brais B, Bouchard JP, Mathieu J. Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay. Mov Disord. 2013 Dec;28(14):2011-4. doi:10.1002/mds.25604. Epub 2013 Aug 2.; Luigetti M, Padua L, Mazza S, et al. Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy. Clin Neurophysiol. 2013 Sep;124(9):1899-903. doi:10.1016/j.clinph.2013.02.116. Epub 2013 May 1.; Mancuso M, Orsucci D, Angelini C, et al. Phenotypic heterogeneity of the 8344A>G mtDNA «MERRF» mutation. Neurology. 2013 May 28;80(22):2049-54. doi:10.1212/WNL.0b013e318294b44c. Epub 2013 May 1.; Stumpf JD, Saneto RP, Copeland WC. Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol. 2013 Apr 1;5(4):a011395. doi:10.1101/cshperspect.a011395.; Debs R, Froissart R, Aubourg P, et al. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metab Dis. 2013;36(5):859-68.; Lagarde J, Roze E, Apartis E, et al. Myoclonus and dystonia in cerebrotendinous xanthomatosis. Mov Disord. 2012 Dec;27(14):1805-10. doi:10.1002/mds.25206. Epub 2012 Oct 31.; Hammer MB, El Euch-Fayache G, Nehdi H, et al. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families. Diagn Mol Pathol. 2012 Dec;21(4):241-5. doi:10.1097/PDM.0b013e318257ad9a.; Apartis E, Blancher A, Meissner WG, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 2012 Oct 30;79(18):1898-907. doi:10.1212/WNL.0b013e318271f7ff. Epub 2012 Oct 17.; Klebe S, Depienne C, Gerber S, et al. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain. 2012 Oct;135(Pt 10):2980-93. doi:10.1093/brain/aws240.; Titlic M, Kodzoman K, Loncar D. Neurologic manifestations of hypereosinophilic syndrome-review of the literature. Acta Clin Croat. 2012 Mar;51(1):65-9.; Eiberg H, Hansen L, Korbo L, et al. Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9). Clin Genet. 2012 Sep;82(3):256-63. doi:10.1111/j.1399-0004.2011.01745.x. Epub 2011 Jul 18.; Regal L, Ebberink MS, Goemans N, et al. Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol. 2010 Aug;68(2):259-63. doi:10.1002/ana.22035.; Perera NJ, Lewis B, Tran H, et al. Refsum's Disease - Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder. J Obes. 2011;2011. pii: 482021. doi:10.1155/2011/482021. Epub 2010 Sep 1.; https://nnp.ima-press.net/nnp/article/view/535Test

  4. 4